Acerus Pharmaceuticals Corporation announced earnings results for the year ended December 31, 2019. For the year, the company announced total revenue was USD 3.768 million compared to USD 7.377 million a year ago. Operating loss was USD 14.036 million compared to USD 16.542 million a year ago. Net loss was USD 16.129 million compared to USD 18.786 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.08 a year ago.